Difference of Clinical Characteristics in Patients with Omicron and Delta Variants of SARS-CoV-2 in

来源 :感染性疾病与免疫(英文) | 被引量 : 0次 | 上传用户:
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Background:

Delta and Omicron are two main variants that have been prevalent since 2021. However, the Omicron variant of severe acute respiratory syndrome coronavirus 2 shows a less severe clinical presentation and high transmissibility. Therefore, we carried out this retrospective study to evaluate Omicron severity compared with the Delta variant and further comprehend the differences in clinical characteristics in patients with the Omicron variant.

Methods:

We extracted clinical data and compared clinical severity, symptoms, vaccination status, laboratory parameters, viral shedding time, and computed tomography (CT) imaging between the two groups of patients, which included 109 COVID-19 cases with the Delta variant and 183 cases with the Omicron variant, from January 19 to April 1, 2022, in Beijing Ditan Hospital. In addition, the Beijing Center for Disease Prevention and Control conducted whole-genome sequencing.

Results:

We obtained 94 strains of variants of concern/Delta and 110 strains of variants of concern/Omicron. For the 110 Omicron strains, three were assigned as BA.1.1, 53 as BA.2, and 54 as BA.2.2. Among patients with the Delta variant, 54% (59/109) were moderate, which was significantly higher than that of patients with the Omicron variant (7% (12/183), P

其他文献
Luteolinisanaturalflavonoidthathasavarietyofpharmacologicalactivities,suchasanti-inflammatory,anti-allergic,anti-bacterial,antiviral,apoptosisinhibition,cellautophagyregulation,andanti-tumoractivity.Itisoneofthemainingredientsofanexpert-recommendedherbalf
Theneutrophil-to-lymphocyteratio(NLR)isanimportantpredictiveprognostictool.However,itsaccuracyforpredictingsepsisremainsdebatable.ThisstudyaimedtoevaluatethefactorsinfluencingtheabilityofNLRtopredictsepsis.AdultpatientswithsepsisorsepticshockfromtheeICUda
期刊
InChina,apilotprojectforthepreventionofmother-to-childtransmission(PMTCT)oftheHIVwasinitiatedin2001.ForthePMTCTofHIV,theChinesegovernmenthasreleasedversionsoftheguidelinessince2004.In2014,theWorldHealthOrganizationreleasedguidanceonglobalprocessesandcrite